Company: RGBP
Filing Date: 2025-06-11
Form Type: 8-K
Source: 0001641172-25-014652
Chunk: 0

Company: Regen BioPharma Inc
Filing Date: 2025-06-11
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item
3.02. Unregistered Sale of Equity Securities

On
June 10, 2025 Regen Biopharma, Inc.(“ Company”} issued 10,000,000 common shares (“ Shares”) to David R. Koos, the
Company’s Chief Executive Officer. The Shares were issued in settlement of $50,000 salary accrued but unpaid earned by David Koos
for services rendered pursuant to that employment agreement entered into by and between the Company and David Koos on February 10, 2015
and to which David Koos and the Company were bound between February 11, 2025 and January 22, 2020.

The
Shares were issued pursuant to Section 4(a) (2) of the Securities Act of 1933, as amended (the “ Act”). No underwriters were
retained to serve as placement agents for the sale. The shares were sold directly through our management. No commission or other consideration
was paid in connection with the sale of the shares. There was no advertisement or general solicitation made in connection with this Offer
and Sale of Shares. A legend was placed on the certificate that evidences the Shares stating that the Shares have not been registered
under the Act and setting forth or referring to the restrictions on transferability and sale of the Shares.

As
a result of the issuance of the Shares as of June 10, 2025 Regen Biopharma, Inc. has 31,554,704 common shares outstanding.

Item
9.01. Financial Statements and Exhibits.

Exhibit 10.1 2025 Settlement Agreement

Exhibit 10.2 2015 Employment Agreement*

104Cover Page Interactive Data File (embedded within the Inline XBRL document)

  Incorporated                                                                                            
  by reference Exhibit 10.2 to that Current Report on Form 8-k filed by the Company on February 13, 2015  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                     REGEN                                             
  Dated:             By:                  /s/                          
                                          David                        
                                          Chairman